In RCC both global mRNA expression profiling of VHL cell line pairs (23–25) and complementary proteomic approaches (7,8,22,26) have succeeded in identifying changes that are relevant in tumourigenesis. The gene discussed is VHL; the disease is renal cell carcinoma.